Basic Information
OliX Pharmaceuticals is a clinical-stage biotechnology company. It is dedicated to developing RNA interference (RNAi) technology therapies for skin, ophthalmic, and pulmonary diseases. The company's pipeline products include OLX101, OLX201, OLX301, OLX102, etc.
OliX Pharmaceuticals, Inc.
Suwon,GyeonggiProvince,SouthKorea
15~50 people
January 01, 2010
olixpharma@olixpharma.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios